Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...
On October 25, 2025, the United States Court of Appeals for the Ninth Circuit reaffirmed a fundamental protection under the National Labor ...
The best management books illuminate something we need to grapple with and provide a foundation for improvement ...
Detailed price information for Cardiol Therapeutics Inc (CRDL-T) from The Globe and Mail including charting and trades.
LITTLE CURRENT—The Expositor sat down with Radio Amateurs of Canada president, Alan Boyd of Little Current to discuss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback